Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 17 Carcinoma, Non-Small-Cell Lung 11 Neoplasm Metastasis 3 Lung Neoplasms 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Squamous Cell Carcinoma of Head and Neck 2 Thymoma 1 Recurrence 1 Pancreatic Neoplasms 1 Neoplasms 1 Metastatic Gastric Adenocarcinoma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Locally Advanced Unresectable Gastric Adenocarcinoma 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Gastroesophageal Cancer 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Clinical Stage IVB Gastric Cancer AJCC v8 1 Clinical Stage III Gastric Cancer AJCC v8 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Hepatocellular 1 Carcinoid Tumor 1 Brain Neoplasms 1

Interventions

Cisplatin 86 Radiotherapy 71 Paclitaxel 50 Fluorouracil 38 Carboplatin 36 Drug Therapy 32 Neoadjuvant Therapy 23 toripalimab 19 tislelizumab 18 pembrolizumab 17 camrelizumab 17 Irinotecan 17 Esophagectomy 17 Surgical Procedures, Operative 16 Radiation 16 Docetaxel 16 sintilimab 15 Oxaliplatin 14 130-nm albumin-bound paclitaxel 14 nimotuzumab 11 TP protocol 11 S 1 (combination) 11 Radiotherapy, Intensity-Modulated 11 Cetuximab 11 Capecitabine 11 Albumin-Bound Paclitaxel 10 apatinib 9 Leucovorin 9 Immune Checkpoint Inhibitors 8 nedaplatin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Esophageal Squamous Cell Carcinoma × Ramucirumab × Clear all

NCT03762564 2022-12-08

RAMOS

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Completed

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡